I’m not sure if cost would be the leading purpose for conducting a clinical study in a developing country but regulations and target audience would probably be. For example, a researcher interested in conducting a study focused around the ZIKA virus would be much better off in a South American country like Brazil, where the disease is much more prominent and they can find a target group much easier.